Skip to main content
SpringerLink
Log in

Toxicant-Induced Hematologic Syndromes

  • Reference work entry
  • First Online:
Critical Care Toxicology

Abstract

Oxidant hemolysis, methemoglobinemia, and sulfhemoglobinemia share common etiologies and frequently coexist in the same patient.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 338.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 379.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Evans AS, Enzer N, Eder HA, Finch CA. Hemolytic anemia with paroxysmal methemoglobinemia and sulfhemoglobinemia; report of 2 cases. Arch Intern Med (Chic). 1950;86(1):22–34.

    Article  CAS  Google Scholar 

  2. Basset P, Bergerat JP, Lang JM, Oberling F, Gillet B. Hemolytic anemia and sulfhemoglobinemia due to phenacetin abuse: a case with multivisceral adverse effects. Clin Toxicol. 1981;18(4):493–9.

    Article  CAS  PubMed  Google Scholar 

  3. Yoo D, Lessin LS. Drug-associated “bite cell” hemolytic anemia. Am J Med. 1992;92(3):243–8.

    Article  CAS  PubMed  Google Scholar 

  4. Curry S. Methemoglobinemia. Ann Emerg Med. 1982;11(4):214–21.

    Article  CAS  PubMed  Google Scholar 

  5. Weatherall DJ, Clegg JB, Higgs DR, et al. The hemoglobinopathies. In: Scriver CR, Beaudet AL, Sly WS, et al., editors. The metabolic basis of inherited disease. New York: McGraw-Hill; 1995. p. 3417–84.

    Google Scholar 

  6. Melzer-Lange M, Walsh-Kelly C. Naphthalene-induced hemolysis in a black female toddler deficient in glucose-6-phosphate dehydrogenase. Pediatr Emerg Care. 1989;5(1):24–6.

    Article  CAS  PubMed  Google Scholar 

  7. Steffen C, Seitz R. Severe chlorate poisoning: report of a case. Arch Toxicol. 1981;48(4):281–8.

    Article  CAS  PubMed  Google Scholar 

  8. Savides MC, Oehme FW, Leipold HW. Effects of various antidotal treatments on acetaminophen toxicosis and biotransformation in cats. Am J Vet Res. 1985;46(7):1485–9.

    CAS  PubMed  Google Scholar 

  9. Iciek M, Polak M, Włodek L. Effect of thiol drugs on the oxidative hemolysis in human erythrocytes. Acta Pol Pharm. 2000;57(6):449–54.

    CAS  PubMed  Google Scholar 

  10. Kondo H, Takahashi M, Niki E. Peroxynitrite-induced hemolysis of human erythrocytes and its inhibition by antioxidants. FEBS Lett. 1997;413(2):236–8.

    Article  CAS  PubMed  Google Scholar 

  11. Martin L, Khalil H. How much reduced hemoglobin is necessary to generate central cyanosis? Chest. 1990;97(1):182–5.

    Article  CAS  PubMed  Google Scholar 

  12. Finch CA. Methemoglobinemia and sulfhemoglobinemia. N Engl J Med. 1948;239(13):470–8.

    Article  CAS  PubMed  Google Scholar 

  13. Jaffe ER, Hultquist DE. Cytochrome b5 reductase deficiency and enzymopenic hereditary methemoglobinemia. In: Scriver CR, Beaudet AL, Sly WS, et al., editors. The metabolic basis of inherited disease. New York: McGraw-Hill; 1995. p. 3399–415.

    Google Scholar 

  14. Kedar PS, Warang P, Ghosh K, Colah RB. Severe mental retardation and recessive congenital methemoglobinemia in three Indian patients: compound heterozygous for NADH-cytochrome b5 reductase gene mutations. Am J Hematol. 2011;86(3):327–9.

    Article  PubMed  Google Scholar 

  15. Yano SS, Danish EH, Hsia YE. Transient methemoglobinemia with acidosis in infants. J Pediatr. 1982;100(3):415–8.

    Article  CAS  PubMed  Google Scholar 

  16. Luk G, Riggs D, Luque M. Severe methemoglobinemia in a 3-week-old infant with a urinary tract infection. Crit Care Med. 1991;19(10):1325–7.

    Article  CAS  PubMed  Google Scholar 

  17. Kern K, Langevin PB, Dunn BM. Methemoglobinemia after topical anesthesia with lidocaine and benzocaine for a difficult intubation. J Clin Anesth. 2000;12(2):167–72.

    Article  CAS  PubMed  Google Scholar 

  18. Stoiber TR. Toxic methemoglobinemia complicating transesophageal echocardiography. Echocardiography. 1999;16(4):383–5.

    Article  PubMed  Google Scholar 

  19. Schroeder TH, Dieterich HJ, Mühlbauer B. Methemoglobinemia after axillary block with bupivacaine and additional injection of lidocaine in the operative field. Acta Anaesthesiol Scand. 1999;43(4):480–2.

    Article  CAS  PubMed  Google Scholar 

  20. Karim A, Ahmed S, Siddiqui R, Mattana J. Methemoglobinemia complicating topical lidocaine used during endoscopic procedures. Am J Med. 2001;111(2):150–3.

    Article  CAS  PubMed  Google Scholar 

  21. Lynch A, Tobias JD. Acute valproate ingestion induces symptomatic methemoglobinemia. Pediatr Emerg Care. 1998;14(3):205–7.

    Article  CAS  PubMed  Google Scholar 

  22. Moreira V, De Medeiros BC, Bonfim CM, Pasquini R, De Medeiros CR. Methemoglobinemia secondary to clofazimine treatment for chronic graft-versus-host disease. Blood. 1998;92(12):4872–3.

    CAS  PubMed  Google Scholar 

  23. Khan AM, Singh NT, Bilgrami S. Flutamide induced methemoglobinemia. J Urol. 1997;157(4):1363.

    Article  CAS  PubMed  Google Scholar 

  24. Hadjiliadis D, Govert JA. Methemoglobinemia after infusion of ifosfamide chemotherapy: first report of a potentially serious adverse reaction related to ifosfamide. Chest. 2000;118(4):1208–10.

    Article  CAS  PubMed  Google Scholar 

  25. Curry SC, Arnold-Capell P. Toxic effects of drugs used in the ICU. Nitroprusside, nitroglycerin, and angiotensin-converting enzyme inhibitors. Crit Care Clin. 1991;7(3):555–81.

    CAS  PubMed  Google Scholar 

  26. Lukens JN. Landmark perspective: the legacy of well-water methemoglobinemia. JAMA. 1987;257(20):2793–5.

    Article  CAS  PubMed  Google Scholar 

  27. Centers for Disease Control and Prevention (CDC). Methemoglobinemia attributable to nitrite contamination of potable water through boiler fluid additives – New Jersey, 1992 and 1996. MMWR Morb Mortal Wkly Rep. 1997;46(9):202–4.

    Google Scholar 

  28. Kennedy N, Smith CP, McWhinney P. Faulty sausage production causing methaemoglobinaemia. Arch Dis Child. 1997;76(4):367–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Hunter L, Gordge L, Dargan PI, Wood DM. Methaemoglobinaemia associated with the use of cocaine and volatile nitrites as recreational drugs: a review. Br J Clin Pharmacol. 2011;72(1):18–26.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Centers for Disease Control and Prevention (CDC). Severe methemoglobinemia and hemolytic anemia from aniline purchased as 2C-E (4-ethyl-2,5-dimethoxyphenethylamine), a recreational drug, on the Internet – Oregon, 2011. MMWR Morb Mortal Wkly Rep. 2012;61(5):85–8.

    Google Scholar 

  31. Shepherd G, Grover J, Klein-Schwartz W. Prolonged formation of methemoglobin following nitroethane ingestion. J Toxicol Clin Toxicol. 1998;36(6):613–6.

    Article  CAS  PubMed  Google Scholar 

  32. Roberts DM, Heilmair R, Buckley NA, et al. Clinical outcomes and kinetics of propanil following acute self-poisoning: a prospective case series. BMC Clin Pharmacol. 2009;9:3.

    Article  PubMed  PubMed Central  Google Scholar 

  33. Brewer GJ, Tarlov AR, Kellermeyer RW, Alving AS. The hemolytic effect of primaquine. XV. Role of methemoglobin. J Lab Clin Med. 1962;59:905–17.

    CAS  PubMed  Google Scholar 

  34. Spurzem JR, Bonekat HW, Shigeoka JW. Factitious methemoglobinemia caused by hyperlipemia. Chest. 1984;86(1):84–6.

    Article  CAS  PubMed  Google Scholar 

  35. Kirlangitis JJ, Middaugh RE, Zablocki A, Rodriquez F. False indication of arterial oxygen desaturation and methemoglobinemia following injection of methylene blue in urological surgery. Mil Med. 1990;155(6):260–2.

    CAS  PubMed  Google Scholar 

  36. Henretig FM, Gribetz B, Kearney T, Lacouture P, Lovejoy FH. Interpretation of color change in blood with varying degree of methemoglobinemia. J Toxicol Clin Toxicol. 1988;26(5–6):293–301.

    Article  CAS  PubMed  Google Scholar 

  37. Shihana F, Dissanayake DM, Buckley NA, Dawson AH. A simple quantitative bedside test to determine methemoglobin. Ann Emerg Med. 2010;55(2):184–9.

    Article  PubMed  PubMed Central  Google Scholar 

  38. Ralston AC, Webb RK, Runciman WB. Potential errors in pulse oximetry. III: effects of interferences, dyes, dyshaemoglobins and other pigments. Anaesthesia. 1991;46(4):291–5.

    Article  CAS  PubMed  Google Scholar 

  39. Feiner JR, Bickler PE. Improved accuracy of methemoglobin detection by pulse CO-oximetry during hypoxia. Anesth Analg. 2010;111(5):1160–7.

    Article  CAS  PubMed  Google Scholar 

  40. Reay DT, Insalaco SJ, Eisele JW. Postmortem methemoglobin concentrations and their significance. J Forensic Sci. 1984;29(4):1160–3.

    Article  CAS  PubMed  Google Scholar 

  41. Steele CW, Spink WW. Methylene blue in the treatment of poisonings associated with methemoglobinemia. N Engl J Med. 1933;208(22):1152–3.

    Article  Google Scholar 

  42. Hartmann AF, Perley AM, Barnett HL. A study of some of the physiological effects of sulfanilamide. II. Methemoglobin formation and its control. J Clin Invest. 1938;17(6):699–710.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  43. Wendel WB. The control of methemoglobinemia with methylene blue. J Clin Invest. 1939;18(2):179–85.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  44. Herman MI, Chyka PA, Butler AY, Rieger SE. Methylene blue by intraosseous infusion for methemoglobinemia. Ann Emerg Med. 1999;33(1):111–3.

    Article  CAS  PubMed  Google Scholar 

  45. Mier RJ. Treatment of aniline poisoning with exchange transfusion. J Toxicol Clin Toxicol. 1988;26(5–6):357–64.

    Article  CAS  PubMed  Google Scholar 

  46. Harrison MR. Toxic methaemoglobinaemia. A case of acute nitrobenzene and aniline poisoning treated by exchange transfusion. Anaesthesia. 1977;32(3):270–2.

    Article  CAS  PubMed  Google Scholar 

  47. Berlin G, Brodin B, Hilden JO, Mårtensson J. Acute dapsone intoxication: a case treated with continuous infusion of methylene blue, forced diuresis and plasma exchange. J Toxicol Clin Toxicol. 1984;22(6):537–48.

    Article  PubMed  Google Scholar 

  48. Southgate HJ, Masterson R. Lessons to be learned: a case study approach: prolonged methaemoglobinaemia due to inadvertent dapsone poisoning; treatment with methylene blue and exchange transfusion. J R Soc Promot Health. 1999;119(1):52–5.

    Article  CAS  PubMed  Google Scholar 

  49. Karadsheh NS, Shaker Q, Ratroat B. Metoclopramide-induced methemoglobinemia in a patient with co-existing deficiency of glucose-6-phosphate dehydrogenase and NADH-cytochrome b5 reductase: failure of methylene blue treatment. Haematologica. 2001;86(6):659–60.

    CAS  PubMed  Google Scholar 

  50. Rosen PJ, Johnson C, McGehee WG, Beutler E. Failure of methylene blue treatment in toxic methemoglobinemia. Association with glucose-6-phosphate dehydrogenase deficiency. Ann Intern Med. 1971;75(1):83–6.

    Article  CAS  PubMed  Google Scholar 

  51. Nadler JE, Green H, Rosenbaum A. Intravenous injection of methylene blue in man with reference to its toxic symptoms and effect on the electrocardiogram. Am J Med Sci. 1934;188(1):15–21.

    Article  CAS  Google Scholar 

  52. Lamont AS, Roberts MS, Holdsworth DG, Atherton A, Shepherd JJ. Relationship between methaemoglobin production and methylene blue plasma concentrations under general anaesthesia. Anaesth Intensive Care. 1986;14(4):360–4.

    CAS  PubMed  Google Scholar 

  53. Stossel TP, Jennings RB. Failure of methylene blue to produce methemoglobinemia in vivo. Am J Clin Pathol. 1966;45(5):600–4.

    Article  CAS  PubMed  Google Scholar 

  54. Way JL, Leung P, Sylvester DM. Methaemoglobin formation in the treatment of acute cyanide intoxication. In: Ballantyne B, Marrs TC, editors. Clinical and experimental toxicology of cyanides. Bristol: IOP Publishing; 1987. p. 402–12.

    Google Scholar 

  55. Liao YP, Hung DZ, Yang DY. Hemolytic anemia after methylene blue therapy for aniline-induced methemoglobinemia. Vet Hum Toxicol. 2002;44(1):19–21.

    PubMed  Google Scholar 

  56. Kirsch IR, Cohen HJ. Heinz body hemolytic anemia from the use of methylene blue in neonates. J Pediatr. 1980;96(2):276–8.

    Article  CAS  PubMed  Google Scholar 

  57. Crooks J. Haemolytic jaundice in a neonate after intra-amniotic injection of methylene blue. Arch Dis Child. 1982;57(11):872–3.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  58. McEnerney JK, McEnerney LN. Unfavorable neonatal outcome after intraamniotic injection of methylene blue. Obstet Gynecol. 1983;61 Suppl 3:35S–7.

    CAS  PubMed  Google Scholar 

  59. Coleman MD, Rhodes LE, Scott AK, et al. The use of cimetidine to reduce dapsone-dependent methaemoglobinaemia in dermatitis herpetiformis patients. Br J Clin Pharmacol. 1992;34(3):244–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  60. Hirano M, Matsuki T, Tanishima K, et al. Congenital methaemoglobinaemia due to NADH methaemoglobin reductase deficiency: successful treatment with oral riboflavin. Br J Haematol. 1981;47(3):353–9.

    Article  CAS  PubMed  Google Scholar 

  61. Kaplan JC, Chirouze M. Therapy of recessive congenital methaemoglobinaemia by oral riboflavine. Lancet. 1978;2(8098):1043–4.

    Article  CAS  PubMed  Google Scholar 

  62. Wright RO, Woolf AD, Shannon MW, Magnani B. N-acetylcysteine reduces methemoglobin in an in-vitro model of glucose-6-phosphate dehydrogenase deficiency. Acad Emerg Med. 1998;5(3):225–9.

    Article  CAS  PubMed  Google Scholar 

  63. Tanen DA, LoVecchio F, Curry SC. Failure of intravenous N-acetylcysteine to reduce methemoglobin produced by sodium nitrite in human volunteers: a randomized controlled trial. Ann Emerg Med. 2000;35(4):369–73.

    Article  CAS  PubMed  Google Scholar 

  64. Park SY, Lee KW, Kang TS. High-dose vitamin C management in dapsone-induced methemoglobinemia. Am J Emerg Med. 2014;32(6):684.e1–e3.

    Article  Google Scholar 

  65. Goluboff N, Wheaton R. Methylene blue induced cyanosis and acute hemolytic anemia complicating the treatment of methemoglobinemia. J Pediatr. 1961;58:86–9.

    Article  CAS  PubMed  Google Scholar 

  66. Chatfield MJ, La Mar GN. 1H nuclear magnetic resonance study of the prosthetic group in sulfhemoglobin. Arch Biochem Biophys. 1992;295(2):289–96.

    Article  CAS  PubMed  Google Scholar 

  67. Park CM, Nagel RL. Sulfhemoglobinemia. Clinical and molecular aspects. N Engl J Med. 1984;310(24):1579–84.

    Article  CAS  PubMed  Google Scholar 

  68. Curry SC, Gerkin RD. A patient with sulfhemoglobin? Ann Emerg Med. 1987;16(7):828–30.

    CAS  PubMed  Google Scholar 

  69. Smith RP, Gosselin RE. Hydrogen sulfide poisoning. J Occup Med. 1979;21(2):93–7.

    Article  CAS  PubMed  Google Scholar 

  70. Mary AM, Bhupalam L. Metoclopramide-induced methemoglobinemia in an adult. J Ky Med Assoc. 2000;98(6):245–7.

    CAS  PubMed  Google Scholar 

  71. Van Veldhuizen PJ, Wyatt A. Metoclopramide-induced sulfhemoglobinemia. Am J Gastroenterol. 1995;90(6):1010–1.

    PubMed  Google Scholar 

  72. Kouides PA, Abboud CN, Fairbanks VF. Flutamide-induced cyanosis refractory to methylene blue therapy. Br J Haematol. 1996;94(1):73–5.

    Article  CAS  PubMed  Google Scholar 

  73. Chawla R, Gurnani A, Bhattacharya A. Acute dapsone poisoning. Anaesth Intensive Care. 1993;21(3):349–51.

    CAS  PubMed  Google Scholar 

  74. Halvorsen SM, Dull WL. Phenazopyridine-induced sulfhemoglobinemia: inadvertent rechallenge. Am J Med. 1991;91(3):315–7.

    Article  CAS  PubMed  Google Scholar 

  75. Azen EA, Bryan GT, Shahidi NT, Rossi EC, Clatanoff DV. Obscure hemolytic anemia due to analgesic abuse. Does enterogenous cyanosis exist? Am J Med. 1970;48(6):724–7.

    Article  CAS  PubMed  Google Scholar 

  76. Westphal RG, Azen EA. Experimental enterogenous cyanosis and anaemia. Br J Haematol. 1972;22(5):609–16.

    Article  CAS  PubMed  Google Scholar 

  77. Levine D, Brunton AT, Kruger A, Hersant M. Recurrent sulphaemoglobinaemia treated with neomycin. J R Soc Med. 2000;93(8):428.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  78. Michel HO, Harris JS. The blood pigments: the properties and quantitative determination with special reference to spectrophotometric methods. J Lab Clin Med. 1940;25(5):445–63.

    CAS  Google Scholar 

  79. Carrico RJ, Peisach J, Alben JO. The preparation and some physical properties of sulfhemoglobin. J Biol Chem. 1978;253(7):2386–91.

    CAS  PubMed  Google Scholar 

  80. Zoppi F, Brenna S, Fumagalli C, Marocchi A. Discrimination among dyshemoglobins: analytical approach to a toxicological query. Clin Chem. 1996;42(8 Pt 1):1300–2.

    CAS  PubMed  Google Scholar 

  81. Demedts P, Wauters A, Watelle M, Neels H. Pitfalls in discriminating sulfhemoglobin from methemoglobin. Clin Chem. 1997;43(6 Pt 1):1098–9.

    CAS  PubMed  Google Scholar 

  82. Zwart A, Buursma A, Oeseburg B, Zijlstra WG. Determination of hemoglobin derivatives with IL 282 CO-oximeter as compared with a manual spectrophotometric five-wavelength method. Clin Chem. 1981;27(11):1903–7.

    CAS  PubMed  Google Scholar 

  83. Aravindhan N, Chisholm DG. Sulfhemoglobinemia presenting as pulse oximetry desaturation. Anesthesiology. 2000;93(3):883–4.

    Article  CAS  PubMed  Google Scholar 

  84. Wu C, Kenny MA. A case of sulfhemoglobinemia and emergency measurement of sulfhemoglobin with an OSM3 CO-oximeter. Clin Chem. 1997;43(1):162–6.

    CAS  PubMed  Google Scholar 

  85. Langford JS, Sheikh S. An adolescent case of sulfhemoglobinemia associated with high-dose metoclopramide and N-acetylcysteine. Ann Emerg Med. 1999;34(4 Pt 1):538–41.

    Article  CAS  PubMed  Google Scholar 

  86. Burgess JL, Hamner AP, Robertson WO. Sulfhemoglobinemia after dermal application of DMSO. Vet Hum Toxicol. 1998;40(2):87–9.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medical Toxicology, Banner – University Medical Center Phoenix, Phoenix, AZ, USA

    Steven C. Curry & A. Min Kang

Authors
  1. Steven C. Curry
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. Min Kang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Steven C. Curry .

Editor information

Editors and Affiliations

  1. Department of Medicine, Division of Clinical Pharmacology and Toxicology, University of Colorado, School of Medicine, Aurora, Colorado, USA

    Jeffrey Brent

  2. FDA, Office of New Drugs/Immediate Office, Center for Drug Evaluation and Research, Silver Spring, Maryland, USA

    Keith Burkhart

  3. Clinical Toxicology, St Thomas’ Hospital, Silver Spring, Maryland, USA

    Paul Dargan

  4. Toxicology Associates, University of Colorado, School of Medicine, Denver, Colorado, USA

    Benjamin Hatten

  5. Medical Toxicological Intensive Care Unit, Lariboisiere Hospital, Paris-Diderot University, Paris, France

    Bruno Megarbane

  6. Toxicology Associates, University of Colorado, School of Medicine, Denver, Colorado, USA

    Robert Palmer

  7. Toxinology Department, Women’s and Children’s Hospital, North Adelaide, South Australia, Australia

    Julian White

Grading System for Levels of Evidence Supporting Recommendations in Critical Care Toxicology, 2nd Edition

  1. I

    Evidence obtained from at least one properly randomized controlled trial.

  2. II-1

    Evidence obtained from well-designed controlled trials without randomization.

  3. II-2

    Evidence obtained from well-designed cohort or case-control analytic studies, preferably from more than one center or research group.

  4. II-3

    Evidence obtained from multiple time series with or without the intervention. Dramatic results in uncontrolled experiments (such as the results of the introduction of penicillin treatment in the 1940s) could also be regarded as this type of evidence.

  5. III

    Opinions of respected authorities, based on clinical experience, descriptive studies and case reports, or reports of expert committees.

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing AG

About this entry

Cite this entry

Curry, S.C., Kang, A.M. (2017). Toxicant-Induced Hematologic Syndromes. In: Brent, J., et al. Critical Care Toxicology. Springer, Cham. https://doi.org/10.1007/978-3-319-17900-1_9

Download citation

Publish with us

Policies and ethics

Search

Navigation